aod9604. aod9604 Produced using quality AOD-9604 5mg

Complementary mechanisms with GLP-1 peptides 5-amino-1mq works through a completely different pathway than GLP-1 receptor agonists like semaglutide , tirzepatide , or retatrutide

Treatment plans prioritize safety, realistic results, and long-term success rather than quick fixes

Treatment upregulated protein translation components and stimulated the transsulfuration pathway for oxidative stress protection, with no reported adverse events (Dimet-Wiley et al., 2024)

It is less preferred but used when there is less chance of absorption through skin

The appropriate route and dose depend on the clinical scenario

When in doubt, consult your pharmacist or Novo Nordisks for clarity.